Atlas Trials

Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease

Clinical trial NCT01513460 · COMPLETED

Trial details

NCT number
NCT01513460
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease
Start date
2012-04-01
Primary completion
2013-12-01
Enrollment
773

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.